Table of Contents
Thrombosis
Volume 2014 (2014), Article ID 753780, 4 pages
http://dx.doi.org/10.1155/2014/753780
Research Article

Cardioembolic Sources in Stroke Patients in South of Brazil

Hospital São Lucas, Instituto do Cérebro, Pontifícia Universidade Católica do Rio Grande do Sul, Avenida Ipiranga 6690, Room 220, 90610-000 Porto Alegre, RS, Brazil

Received 30 June 2014; Revised 24 September 2014; Accepted 24 September 2014; Published 2 October 2014

Academic Editor: Thomas Kickler

Copyright © 2014 Luiz Carlos Porcello Marrone et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. C. Porcello Marrone, L. P. Diogo, F. M. de Oliveira et al., “Risk factors among stroke subtypes in Brazil,” Journal of Stroke and Cerebrovascular Diseases, vol. 22, no. 1, pp. 32–35, 2013. View at Publisher · View at Google Scholar · View at Scopus
  2. J. J. F. de Carvalho, M. B. Alves, G. Á. A. Viana et al., “Stroke epidemiology, patterns of management, and outcomes in Fortaleza, Brazil: a hospital-based multicenter prospective study,” Stroke, vol. 42, no. 12, pp. 3341–3346, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. G. Saposnik and O. H. Del Brutto, “Stroke in South America: a systematic review of incidence, prevalence, and stroke subtypes,” Stroke, vol. 34, no. 9, pp. 2103–2107, 2003. View at Publisher · View at Google Scholar · View at Scopus
  4. H. P. Adams Jr., B. H. Bendixen, L. J. Kappelle et al., “Classification of subtype of acute ischemic stroke: definitions for use in a multicenter clinical trial,” Stroke, vol. 24, no. 1, pp. 35–41, 1993. View at Publisher · View at Google Scholar · View at Scopus
  5. M. J. O’Donnell, X. Denis, L. Liu et al., “Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study,” The Lancet, vol. 376, no. 9735, pp. 112–123, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. H. Ihle-Hansen, B. Thommessen, T. B. Wyller, K. Engedal, and B. Fure, “Risk factors for and incidence of subtypes of ischemic stroke,” Functional Neurology, vol. 27, no. 1, pp. 35–40, 2012. View at Google Scholar · View at Scopus
  7. L. R. Caplan, Caplan's Stroke: A Clinical Approach, Saunders Elsevier, Philadelphia, Pa, USA, 4th edition, 2009.
  8. S. J. Connolly, M. D. Ezekowitz, S. Yusuf et al., “Dabigatran versus warfarin in patients with atrial fibrillation,” New England Journal of Medicine, vol. 361, no. 12, pp. 1139–1151, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. P. Amarenco, J. Bogousslavsky, L. R. Caplan, G. A. Donnan, and M. G. Hennerici, “Classification of stroke subtypes,” Cerebrovascular Diseases, vol. 27, no. 5, pp. 493–501, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. L. G. Stead, R. M. Gilmore, M. F. Bellolio et al., “Cardioembolic but not other stroke subtypes predict mortality independent of stroke severity at presentation,” Stroke Research and Treatment, vol. 2011, Article ID 281496, 5 pages, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. J. M. Ferro, “Cardioembolic stroke: an update,” The Lancet Neurology, vol. 2, no. 3, pp. 177–188, 2003. View at Publisher · View at Google Scholar · View at Scopus
  12. C. A. Molina, J. Montaner, S. Abilleira et al., “Timing of spontaneous recanalization and risk of hemorrhagic transformation in acute cardioembolic stroke,” Stroke, vol. 32, no. 5, pp. 1079–1084, 2001. View at Publisher · View at Google Scholar · View at Scopus
  13. R. P. Capmany, A. Arboix, R. Casañas-Muñoz, and N. Anguera-Ferrando, “Specific cardiac disorders in 402 consecutive patients with ischaemic cardioembolic stroke,” International Journal of Cardiology, vol. 95, no. 2-3, pp. 129–134, 2004. View at Publisher · View at Google Scholar · View at Scopus
  14. E. A. Bocchi, G. Guimarães, F. Tarasoutshi, G. Spina, S. Mangini, and F. Bacal, “Cardiomyopathy, adult valve disease and heart failure in South America,” Heart, vol. 95, no. 3, pp. 181–189, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. J. O. Dias Junior, M. O. da Costa Rocha, A. C. de Souza et al., “Assessment of the source of ischemic cerebrovascular events in patients with Chagas disease,” International Journal of Cardiology, 2014. View at Publisher · View at Google Scholar
  16. F. J. Carod-Artal, “Policy implications of the changing epidemiology of chagas disease and stroke,” Stroke, vol. 44, no. 8, pp. 2356–2360, 2013. View at Publisher · View at Google Scholar · View at Scopus
  17. F. J. Carod-Artal, J. O. Casanova Lanchipa, L. M. Cruz Ramírez et al., “Stroke subtypes and comorbidity among ischemic stroke patients in brasilia and cuenca: a brazilian-spanish cross-cultural study,” Journal of Stroke and Cerebrovascular Diseases, vol. 23, no. 1, pp. 140–147, 2014. View at Publisher · View at Google Scholar · View at Scopus
  18. M. R. Patel, K. W. Mahaffey, J. Garg et al., “Rivaroxaban versus warfarin in nonvalvular atrial fibrillation,” New England Journal of Medicine, vol. 365, no. 10, pp. 883–891, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. C. B. Granger, J. H. Alexander, J. J. V. McMurray et al., “Apixaban versus warfarin in patients with atrial fibrillation,” The New England Journal of Medicine, vol. 365, no. 11, pp. 981–992, 2011. View at Publisher · View at Google Scholar